Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage
- PMID: 34080435
- DOI: 10.1021/acs.jproteome.1c00054
Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage
Abstract
The COVID-19 pandemic has become a worldwide health crisis. So far, most studies have focused on the epidemiology and pathogenesis of this infectious disease. Little attention has been given to the disease sequelae in patients recovering from COVID-19, and nothing is known about the mechanisms underlying these sequelae. Herein, we profiled the serum proteome of a cohort of COVID-19 patients in the disease onset and recovery stages. Based on the close integration of our proteomic analysis with clinical data, we propose that COVID-19 is associated with prolonged disorders in cholesterol metabolism and myocardium, even in the recovery stage. We identify potential biomarkers for these disorders. Moreover, severely affected patients presented more serious disturbances in these pathways. Our findings potentially support clinical decision-making to improve the prognosis and treatment of patients.
Keywords: COVID-19; cardiomyopathy; cholesterol metabolism; quantitative proteomics; sequelae.
Similar articles
-
COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.Int J Mol Sci. 2022 Feb 22;23(5):2414. doi: 10.3390/ijms23052414. Int J Mol Sci. 2022. PMID: 35269564 Free PMC article. Review.
-
Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies.Front Immunol. 2022 Jul 26;13:893943. doi: 10.3389/fimmu.2022.893943. eCollection 2022. Front Immunol. 2022. PMID: 35958562 Free PMC article.
-
Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19.Front Immunol. 2022 Nov 3;13:1027122. doi: 10.3389/fimmu.2022.1027122. eCollection 2022. Front Immunol. 2022. PMID: 36405747 Free PMC article.
-
Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology.Front Immunol. 2021 Sep 8;12:730710. doi: 10.3389/fimmu.2021.730710. eCollection 2021. Front Immunol. 2021. PMID: 34566994 Free PMC article.
-
Mass Spectrometry-Based Proteomics Research to Fight COVID-19: An Expert Review on Hopes and Challenges.OMICS. 2022 Jan;26(1):19-34. doi: 10.1089/omi.2021.0182. Epub 2022 Jan 7. OMICS. 2022. PMID: 35005991 Review.
Cited by
-
COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.Int J Mol Sci. 2022 Feb 22;23(5):2414. doi: 10.3390/ijms23052414. Int J Mol Sci. 2022. PMID: 35269564 Free PMC article. Review.
-
COVID Vaccination as a Strategy for Cardiovascular Disease Prevention.Curr Cardiol Rep. 2023 Oct;25(10):1327-1335. doi: 10.1007/s11886-023-01950-2. Epub 2023 Sep 9. Curr Cardiol Rep. 2023. PMID: 37688764 Review.
-
Deciphering the assembly process of PQQ dependent methanol dehydrogenase.Nat Commun. 2025 Jul 19;16(1):6672. doi: 10.1038/s41467-025-61958-w. Nat Commun. 2025. PMID: 40683858 Free PMC article.
-
Deep proteomic analysis of obstetric antiphospholipid syndrome by DIA-MS of extracellular vesicle enriched fractions.Commun Biol. 2024 Jan 15;7(1):99. doi: 10.1038/s42003-024-05789-3. Commun Biol. 2024. PMID: 38225453 Free PMC article.
-
Risks and burdens of incident dyslipidaemia in long COVID: a cohort study.Lancet Diabetes Endocrinol. 2023 Feb;11(2):120-128. doi: 10.1016/S2213-8587(22)00355-2. Epub 2023 Jan 6. Lancet Diabetes Endocrinol. 2023. PMID: 36623520 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical